The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells

This publication has 15 references indexed in Scilit:

• An Evidence-based Staging System for Cutaneous Melanoma
  CA: A Cancer Journal for Clinicians, 2004
• Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells
  Annals of the New York Academy of Sciences, 2003
• Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling
  Journal of Biological Chemistry, 2003
• Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3′-Kinase Activity in Breast Cancer Cells
  Published by Elsevier ,2003
• The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
  Cancer and Metastasis Reviews, 2003
• The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
  Nature, 2000
• Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity
  The Journal of Experimental Medicine, 1997
• The FcεRIβ Subunit Functions as an Amplifier of FcεRIγ-Mediated Cell Activation Signals
  Cell, 1996
• Syk tyrosine kinase required for mouse viability and B-cell development
  Nature, 1995
• Cutaneous Melanoma
  New England Journal of Medicine, 1991